UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Prognosis of lymph node metastasis in soft tissue sarcoma

Annals of surgical oncology, 2004-07, Vol.11 (7), p.714-719

2004

Link zum Volltext

Verfügbarkeit prüfen

Significant Clinical Benefit of First-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma : Retrospective Analysis and Identification of Prognostic Factors in 488 Patients

Cancer, 2008-04, Vol.112 (7), p.1585-1591

2008

Link zum Volltext

Verfügbarkeit prüfen

Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis

European journal of cancer (1990), 2009-11, Vol.45 (17), p.2930-2934

2009

Link zum Volltext

Verfügbarkeit prüfen

Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread

Radiology, 2003-02, Vol.226 (2), p.527

2003

Link zum Volltext

Verfügbarkeit prüfen

Role of palliative chemotherapy in advanced epithelioid sarcoma

American journal of clinical oncology, 2012-08, Vol.35 (4), p.351-357

2012

Link zum Volltext

Verfügbarkeit prüfen

Metastatic soft tissue sarcoma, an analysis of systemic therapy and impact on survival

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.10545-10545

2015

Link zum Volltext

Verfügbarkeit prüfen

Angiosarcoma of the face and scalp: Effective systemic treatment in the older patient

Journal of geriatric oncology, 2014-07, Vol.5 (3), p.276-280

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma

Sarcoma, 2013, Vol.2013, p.868973-6

2013

Link zum Volltext

Verfügbarkeit prüfen

Low-grade Fibromyxoid Sarcoma: Treatment Outcomes and Efficacy of Chemotherapy

In vivo (Athens), 2020-01, Vol.34 (1), p.239-245

2020

Link zum Volltext

Verfügbarkeit prüfen

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma

Clinical sarcoma research, 2015-03, Vol.5 (1), p.10-10, Article 10

2015

Link zum Volltext

Verfügbarkeit prüfen

Significant clinical benefit of first‐line palliative chemotherapy in advanced soft‐tissue sarcoma

Cancer, 2008-04, Vol.112 (7), p.1585-1591

2008

Link zum Volltext

Verfügbarkeit prüfen

Differential sensitivity of liposarcoma subtypes to chemotherapy

European journal of cancer (1990), 2005-12, Vol.41 (18), p.2853-2860

2005

Link zum Volltext

Verfügbarkeit prüfen

Clinical Benefit of Second-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma

Sarcoma, 2010, Vol.2010, p.264360-8

2010

Link zum Volltext

Verfügbarkeit prüfen

Systemic treatment options for epithelioid haemangioendothelioma: the Royal Marsden Hospital experience

Anticancer research, 2015-01, Vol.35 (1), p.473-480

2015

Link zum Volltext

Verfügbarkeit prüfen

A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experience

Anticancer research, 2014-07, Vol.34 (7), p.3663-3668

2014

Link zum Volltext

Verfügbarkeit prüfen

Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance

Annals of surgical oncology, 2019-12, Vol.26 (13), p.4699-4706

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatments and Outcomes in Oligometastatic Soft Tissue Soft Sarcoma – A Single Centre Retrospective Analysis

Anticancer research, 2021-10, Vol.41 (10), p.5089-5096

2021

Link zum Volltext

Verfügbarkeit prüfen

Advanced aggressive fibromatosis: Effective palliation with chemotherapy

Acta oncologica, 2011-04, Vol.50 (3), p.455-461

2011

Link zum Volltext

Verfügbarkeit prüfen

Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour

Acta oncologica, 2012-04, Vol.51 (4), p.550-554

2012

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine Re-challenge in Metastatic Soft Tissue Sarcomas: A Therapeutic Option for Selected Patients

Anticancer research, 2019-01, Vol.39 (1), p.347-351

2019

Link zum Volltext

Verfügbarkeit prüfen

Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre

Clinical sarcoma research, 2020-01, Vol.10 (1), p.1, Article 1

2020

Link zum Volltext

Verfügbarkeit prüfen

Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma

Medical oncology (Northwood, London, England), 2018-10, Vol.35 (10), p.131-5, Article 131

2018

Link zum Volltext

Verfügbarkeit prüfen

Epithelioid haemangioendothelioma

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.10569-10569

2013

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy in clear cell sarcoma

Medical oncology (Northwood, London, England), 2011-09, Vol.28 (3), p.859-863

2011

Link zum Volltext

Verfügbarkeit prüfen

Palliative ambulatory 14-day infusional ifosfamide in the outpatient setting for treatment of advanced soft tissue sarcomas (STS): “Old wine in a new bottle.”

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.10039-10039

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Oncology
(22)
Science & Technology
(22)
Female
(14)
Humans
(14)
Male
(14)
Middle Aged
(13)
Chemotherapy
(12)
Retrospective Studies
(12)
Adult
(11)
Sarcoma
(10)
Aged
(9)
Adolescent
(7)
Tumors
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Follow-Up Studies
(6)
Metastasis
(6)
Prognosis
(6)
Treatment Outcome
(6)
Young Adult
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognosis of lymph node metastasis in soft tissue sarcoma

Significant Clinical Benefit of First-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma : Retrospective Analysis and Identification of Prognostic Factors in 488 Patients

Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis

Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread

Role of palliative chemotherapy in advanced epithelioid sarcoma

Metastatic soft tissue sarcoma, an analysis of systemic therapy and impact on survival

Angiosarcoma of the face and scalp: Effective systemic treatment in the older patient

Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma

Low-grade Fibromyxoid Sarcoma: Treatment Outcomes and Efficacy of Chemotherapy

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma

Significant clinical benefit of first‐line palliative chemotherapy in advanced soft‐tissue sarcoma

Differential sensitivity of liposarcoma subtypes to chemotherapy

Clinical Benefit of Second-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma

Systemic treatment options for epithelioid haemangioendothelioma: the Royal Marsden Hospital experience

A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experience

Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance

Treatments and Outcomes in Oligometastatic Soft Tissue Soft Sarcoma – A Single Centre Retrospective Analysis

Advanced aggressive fibromatosis: Effective palliation with chemotherapy

Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour

Gemcitabine Re-challenge in Metastatic Soft Tissue Sarcomas: A Therapeutic Option for Selected Patients

Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre

Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma

Epithelioid haemangioendothelioma

Chemotherapy in clear cell sarcoma

Palliative ambulatory 14-day infusional ifosfamide in the outpatient setting for treatment of advanced soft tissue sarcomas (STS): “Old wine in a new bottle.”

Suchergebnisse filtern